EMERGING STRONGER FROM THE CHINA CRISIS (p 1311)April 16, 2003Issue 19 April 2003 Embargoed 0001 h (London time) 18 April 2003 This week's Lancet Editorial comments on how China can learn from mistakes made in its handling of the SARS crisis-especially in relation to the increasing prevalence of HIV/AIDS. 'China's lack of openness about SARS is unfortunately reminiscent of its historic response to other health challenges the country faces, including a high suicide rate, especially among women, problems with the safety of its blood supply, and a rapid spread of HIV/AIDS', comments the editorial. It also points out how slow information-gathering from rural districts and a secretive attitude to national health statistics are problems common to China and are issues that present challenges to new leaders of a country that have recently joined the World Trade Organisation and a country that will be under the global spotlight when it hosts the 2008 Olympics. The editorial concludes: "Once it has provided full and accurate information that will enable SARS to be brought under control, China might well turn its attention to another infectious disease crisis. A concerted effort to compile accurate statistics on the prevalence of HIV/AIDS would demonstrate that China is able to learn from its mistakes, and agile and wise enough to acknowledge its responsibilities not only to its own citizens but also to the rest of the world'. | |||||||||||||||||||||
|
Related AIDS Current Events and AIDS News Articles Landmark study defines benefits of early HIV testing and treatment for infected infants Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. First Holistic Guide to Primate Disease Covers Critical Gap in Global Health Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them? Applying 'supply and demand' business principles to treat infectious diseases worldwide Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. Results of landmark study of HIV vaccine published in the Lancet Results from the Step study, a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published online today in two papers in The Lancet. These analyses of the Step study are being conducted, presented and published to inform the continued search for an effective HIV vaccine. Stem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in the October issue of the journal Stem Cells, suggest dental pulp stem cells show promise for use in cell therapy and regenerative medicine, particularly therapies associated with the central nervous system. A new approach in tsunami-early warning The newly implemented Tsunami Early Warning System for the Indian Ocean, GITEWS, goes into operation today and with this, the system enters its final phase of optimisation. Researchers describe how cells take out the trash to prevent disease Garbage collectors are important for removing trash; without them waste accumulates and can quickly become a health hazard. Similarly, individual cells that make up such biological organisms as humans also have sophisticated methods for managing waste. Researchers use chemical from medicinal plants to fight HIV Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised. T cell-based HIV vaccine candidate demonstrates positive results The question of whether or not to continue to pursue the development of T-cell-based HIV-1 vaccines has been a source of controversy following last year's widely publicized failure of the field's most promising candidate, a vaccine developed by Merck known as V520. New study shows that important gene controls the ability of the thymus to produce disease-fighting T-cells after an organism's birth New research, just published by researchers from the University of Georgia, provides the first evidence that a key gene may be crucial to maintaining the production of the thymus and its disease-fighting T-cells after an animal's birth. More AIDS Current Events and AIDS News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||